Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2024

Dec 3, 2024

30442_dirs_2024-12-03_ddce068c-4b51-4537-a590-d13337295083.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2024-11-29

Reporting Person: Carley Brian T (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-11-29 Restricted Stock Unit $ A 249 Acquired Common Stock (249) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 21830 Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.